Showing results (891-900 of 908) with videos related to

Sort By:
Pageof 91
The Science of the Total Environment|August 21, 2021
The effect of agricultural intensification and water-locking on the world's largest coastal lagoonal systemC Bueno, F L Alves, L M Pinheiro, et al.
Lupus|January 31, 2017
Outcomes of 847 childhood-onset systemic lupus erythematosus patients in three age groupsS R M Lopes, N W S Gormezano, R C Gomes, et al.
Annals of the Rheumatic Diseases|May 14, 2026
International expert consensus recommendations on standardised nomenclature of SSA/Ro (TROVE2/Ro60 and TRIM21/Ro52) autoantibodies in autoimmune diseasesRoko P A Nikolic, Eldad Ben-Chetrit, Marvin J Fritzler, et al.
Psychological Medicine|June 16, 2018
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trialFernanda Palhano-Fontes, Dayanna Barreto, Heloisa Onias, et al.
Transplantation Proceedings|June 4, 2015
Collaborative Brazilian Pediatric Renal Transplant Registry (CoBrazPed-RTx): A Report From 2004 to 2013C Garcia, J M Pestana, S Martins, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|June 26, 2020
Phytochemical characterization of the Ziziphus joazeiro Mart. metabolites by UPLC-QTOF and antifungal activity evaluationJacqueline C Andrade, Antônia T L Dos Santos, Ana R P Da Silva, et al.
Clinical Chemistry and Laboratory Medicine|March 29, 2023
Detection of antinuclear antibodies: recommendations from EFLM, EASI and ICAPCarolien Bonroy, Martine Vercammen, Walter Fierz, et al.
Autoimmunity Reviews|November 9, 2020
Childhood-onset systemic lupus erythematosus-related antiphospholipid syndrome: A multicenter study with 1519 patientsAline G Islabão, Licia M H Mota, Maria Custodia M Ribeiro, et al.
American Heart Journal|June 20, 2006
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events, , S Connolly, et al.
BMJ (Clinical Research Ed.)|January 21, 2021
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trialViviane C Veiga, João A G G Prats, Danielle L C Farias, et al.
Pageof 91